Continuous versus intermittent beta-lactam antibiotic infusions in critically ill patients: The UK cohort of the BLING III trial
The findings in the UK cohort are consistent with the conclusions drawn from the global BLING III trial. It seems reasonable to conclude the finding are applicable to the UK.
Authors
- Serena Knowles (ORCID: https://orcid.org/0000-0002-5028-3825)
- Greg Barton (ORCID: https://orcid.org/0000-0001-8560-1734)
- Xiaoqiu Liu (ORCID: https://orcid.org/0000-0001-8620-6592)
- Joel M. Dulhunty (ORCID: https://orcid.org/0000-0002-4524-0548)
- John Myburgh (ORCID: https://orcid.org/0000-0003-4088-7016)
- Dorrilyn Rajbhandari
- Janis Best-Lane (ORCID: https://orcid.org/0000-0003-2528-898X)
- Jeffrey Lipman (ORCID: https://orcid.org/0000-0002-5965-9876)
- Jayanthi Mysore
- Naomi E. Hammond (ORCID: https://orcid.org/0000-0002-6559-7747)
- Stephen J. Brett (ORCID: https://orcid.org/0000-0003-4545-8413)
- Farah Al-Beidh (ORCID: https://orcid.org/0000-0003-4701-463X)
Institutions
- Imperial College Healthcare NHS Trust (GB)
- The University of Queensland (AU)
- Royal Brisbane and Women's Hospital (AU)
- Royal North Shore Hospital (AU)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Queensland Eye Institute (AU)
- The George Institute for Global Health (AU)
- St George Hospital (AU)
- Redcliffe Hospital (AU)
- George Institute for Global Health (CN)
- Imperial College London (GB)
- Université de Nîmes (FR)
Publication Details
- Journal
- Journal of the Intensive Care Society
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1177/17511437251396871
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00